PUMA, ADRIANA
 Distribuzione geografica
Continente #
NA - Nord America 379
EU - Europa 174
AS - Asia 126
AF - Africa 52
SA - Sud America 36
Totale 767
Nazione #
US - Stati Uniti d'America 377
IT - Italia 68
SG - Singapore 66
IE - Irlanda 42
CN - Cina 40
CI - Costa d'Avorio 36
BR - Brasile 32
DE - Germania 17
SN - Senegal 15
GB - Regno Unito 8
RU - Federazione Russa 8
CZ - Repubblica Ceca 6
SE - Svezia 5
TR - Turchia 5
UZ - Uzbekistan 5
BE - Belgio 4
IN - India 4
FI - Finlandia 3
NO - Norvegia 3
AR - Argentina 2
CA - Canada 2
CH - Svizzera 2
EC - Ecuador 2
HK - Hong Kong 2
PL - Polonia 2
ES - Italia 1
FR - Francia 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 767
Città #
Chandler 97
Santa Clara 80
Singapore 49
Dublin 42
Chicago 39
Abidjan 36
Ashburn 18
Catania 17
Civitanova Marche 15
Dakar 15
Boardman 12
Andover 11
Cambridge 11
Lawrence 11
Grafing 8
Brno 6
Des Moines 6
Munich 6
Los Angeles 5
Bari 4
Beijing 4
Brussels 4
Nanjing 4
Pune 4
Wilmington 4
Edinburgh 3
Fantina 3
Hanover 3
New York 3
Oslo 3
Palermo 3
Saint Petersburg 3
São Paulo 3
Aci Catena 2
Belo Horizonte 2
Council Bluffs 2
Cáceres 2
Helsinki 2
Houston 2
Jiaxing 2
London 2
Marília 2
Newham 2
Santa Venerina 2
Seattle 2
Tashkent 2
Zhengzhou 2
Ahmetli 1
Amman 1
Athens 1
Barretos 1
Belém 1
Boa Esperança 1
Bratislava 1
Cabo Frio 1
Caldas Novas 1
Casablanca 1
Cascavel 1
Cesa 1
Chengdu 1
Cianorte 1
Contagem 1
Cuenca 1
Curitiba 1
Fairfield 1
Grosseto 1
Guatraché 1
Hebei 1
Istanbul 1
Itapuranga 1
Jaguarão 1
Jinan 1
Joinville 1
Kilis 1
Kocaeli 1
Lappeenranta 1
Luxembourg 1
Lviv 1
Madrid 1
Magé 1
Manchester 1
Maringá 1
Mascali 1
Merlo 1
Milan 1
Montreal 1
Moscow 1
Nanchang 1
Nanyang 1
Nova Alvorada do Sul 1
Paulo Afonso 1
Paço do Lumiar 1
Polska 1
Quito 1
Redmond 1
Redwood City 1
Salvaterra 1
Santana do Ipanema 1
Shenzhen 1
Simões Filho 1
Totale 613
Nome #
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 83
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 82
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 80
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 78
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 77
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 76
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 71
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 71
Opportunities and challenges of liquid biopsy in thyroid cancer 62
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 60
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 60
Totale 800
Categoria #
all - tutte 3.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 0 0 0 0 7 11
2020/202128 2 0 2 5 7 0 0 1 9 1 0 1
2021/202278 0 13 5 1 19 2 11 3 2 0 2 20
2022/2023233 12 23 7 33 11 37 0 49 44 3 10 4
2023/2024119 6 21 1 1 4 40 0 9 0 7 23 7
2024/2025304 8 62 16 33 62 49 35 10 9 17 3 0
Totale 800